ArticleCell biochemistry and biophysics2024

Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway.

Guojian Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.